Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air® approach
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Bousquet, Jean
- dc.contributor.author Antó i Boqué, Josep Maria
- dc.contributor.author Basagaña Flores, Xavier
- dc.contributor.author Zuberbier, Torsten
- dc.date.accessioned 2023-03-13T07:13:19Z
- dc.date.available 2023-03-13T07:13:19Z
- dc.date.issued 2023
- dc.description.abstract MASK-air® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Santé on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma.
- dc.format.mimetype application/pdf
- dc.identifier.citation Bousquet J, Anto JM, Sousa‐Pinto B, Czarlewski W, Bedbrook A, Haahtela T, et al. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: the ARIA‐MASK‐air® approach. Clinical & Translational All. 2023 Jan;13(1):e12215. DOI: 10.1002/clt2.12215
- dc.identifier.doi http://dx.doi.org/10.1002/clt2.12215
- dc.identifier.issn 2045-7022
- dc.identifier.uri http://hdl.handle.net/10230/56164
- dc.language.iso eng
- dc.publisher Wiley
- dc.relation.ispartof Clinical & Translational All. 2023 Jan;13(1):e12215
- dc.rights © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri https://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword MASK-air
- dc.subject.keyword Asthma
- dc.subject.keyword Digital
- dc.subject.keyword mHealth
- dc.subject.keyword Rhinitis
- dc.title Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air® approach
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion